查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790431

家庭輸液治療市場規模、佔有率和趨勢分析報告：按類型、應用、地區和細分市場預測，2025 年至 2030 年

Home Infusion Therapy Market Size, Share & Trends Analysis Report By Type (Product, Services), By Application (Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

家庭輸液治療市場摘要

2024 年全球家庭輸液治療市值為 386.6 億美元，預計到 2030 年將達到 617.2 億美元，2025 年至 2030 年的複合年成長率為 8.2%。家庭輸液治療涉及透過靜脈輸液將治療、藥物和液體直接輸送到患者的血液中。

市場成長受到多種關鍵因素的推動，包括行動能力下降的老年人口不斷擴大、對居家照護的偏好增加以及技術的快速進步。輸液療法包括靜脈輸液療法和水合療法等關鍵組成部分，在解決口服藥物無法有效治療的疾病（如免疫力缺乏、癌症和鬱血性）心臟衰竭發揮著至關重要的作用。這些治療的需求不斷成長是由患者對長期治療的需求所驅動的，而居家輸液療法正成為治療方法。在輸液療法和靜脈水合療法的推動下，患者越來越能夠在自己舒適的家中獲得有效且個人化的醫療保健解決方案。

居家輸液治療的成本效益是推動其在全球醫療保健系統中被採用的主要因素。透過在醫院外提供輸液治療，住院、再入院和延長住院時間等住院護理相關費用可顯著降低。這種模式降低了直接治療成本，並最大限度地減少了輔助費用，例如設施管理費用和員工人事費用。與傳統住院護理相比，居家輸液治療可顯著節省成本，使其成為對患者和醫療保健支付者有吸引力的選擇。例如，根據美國家庭輸液協會 (NHIA) 的數據，家庭輸液治療每天的費用約為 122 至 225 美元。相比之下，住院護理每天的費用為 586 至 798 美元，具體取決於治療方案。

隨著嬰兒潮世代人口不斷成長，他們因癱瘓、骨關節炎和糖尿病等疾病而行動不便，預計家庭輸液治療的需求將會成長。減少住院時間的迫切需求也是推動市場成長的重要因素。值得注意的是，持續皮下輸注阿樸嗎啡是治療帕金森氏症 (PD) 的一種非常有效的治療方法，並且有各種劑型可以透過皮下給藥來治療 PD。為了應對日益加重的 PD 負擔，對皮下輸液治療的需求顯著增加。例如，根據帕金森基金會 2022 年的數據更新，美國每年約有 9 萬人被診斷出患有 PD。此外，預計到 2030 年，美國的 PD 患者數量將激增至近 120 萬人。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 家庭輸液治療市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 居家輸液治療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 家庭輸液治療市場：按類型估計和趨勢分析

  • 細分儀表板
  • 家庭輸液治療市場趨勢分析（按類型）
  • 2018-2030年全球家庭輸液治療市場規模及趨勢分析（按類型）
  • 產品
    • 點滴幫浦
    • 彈性體
    • 電子機械
    • 重力
    • 其他
    • 靜脈輸液器
    • 靜脈插管
    • 無針頭連接器
  • 服務

第5章：家庭輸液治療市場：按應用的估計和趨勢分析

  • 根據用途細分儀表板
  • 居家輸液治療市場趨勢分析（按應用）
  • 2018-2030年全球家庭輸液治療市場規模及應用趨勢分析
  • 抗感染
  • 內分泌學
    • 糖尿病
    • 其他
  • 水化療法
    • 運動員
    • 其他
  • 化療
  • 經腸營養
  • 經腸營養
  • 特種製藥
  • 其他

第6章：家庭輸液治療市場：區域估計與趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 各地區連續生物加工市場：關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞士
    • 俄羅斯
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 馬來西亞
    • 新加坡
    • 泰國
    • 菲律賓
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
  • 中東和非洲（MEA）
    • 阿根廷
    • 南非
    • 南阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 埃及

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 2024 年主要企業熱圖分析
  • 公司簡介
    • Baxter
    • B. Braun SE
    • BD
    • Fresenius Kabi AG
    • ICU Medical, Inc.
    • Terumo Corporation
    • JMS Co. Ltd.
    • Option Care Health, Inc.
    • CareCentrix, Inc.
    • Coram LLC.
    • PharMerica Corporation
    • Moog Inc.
    • Amedisys, Inc.
Product Code: 978-1-68038-389-8

Home Infusion Therapy Market Summary

The global home infusion therapy market was valued at USD 38.66 billion in 2024 and is expected to reach USD 61.72 billion by 2030, growing at a CAGR of 8.2% from 2025 to 2030. Home infusion therapy involves delivering treatments, medications, or fluids directly into a patient's bloodstream through intravenous (IV) infusion, usually in the comfort and convenience of their home.

The market's growth is driven by several key factors, including the expanding geriatric population characterized by decreased mobility, a rising preference for home care, and the swift evolution of technological advancements. Infusion therapy, encompassing essential components like IV therapy and IV hydration therapy, plays a crucial role in addressing conditions such as immune deficiencies, cancer, and congestive heart failure, where oral medication is not a viable treatment option. The increasing demand for these therapies stems from the need for long-term treatment among patients, positioning home infusion therapy as a notably cost-effective alternative to hospital-based care. Incorporating IV therapy and IV hydration therapy serves as a driving force, providing patients with enhanced accessibility to effective and personalized medical solutions in the comfort of their homes.

The cost-effectiveness of home infusion therapy is a major factor driving its adoption across global healthcare systems. Enabling IV treatments outside hospital settings significantly reduces expenses associated with inpatient care, including hospital admissions, re-admissions, and extended stays. This model lowers direct treatment costs and minimizes ancillary expenditures such as facility overhead and staffing. Home infusion therapy offers substantial cost savings compared to traditional inpatient care, making it an attractive option for patients and healthcare payers. For instance,according to the National Home Infusion Association (NHIA), home infusion therapy costs approximately USD 122 to USD 225 per day. In contrast, inpatient care can range from USD 586 to USD 798 per day, depending on the therapy administered.

The increasing demographic of baby boomers struggling with diminished mobility due to conditions such as paralysis, osteoarthritis, and diabetes is expected to amplify the demand for home infusion therapy. The growing imperative to reduce the duration of inpatient stays is a pivotal factor poised to contribute significantly to the market's growth. Remarkably, continuous subcutaneous (SC) apomorphine infusion emerges as an exceptionally effective treatment for Parkinson's disease (PD), with diverse drug formulations available for the management of PD through subcutaneous delivery. In response to the mounting burden of PD, there is a notable surge in the demand for subcutaneous infusion therapy. For instance, in line with the Parkinson's Foundation's 2022 data update, approximately 90,000 individuals receive a PD diagnosis annually in the U.S. Furthermore, the anticipated number of people living with PD in the country is projected to soar to nearly 1.2 million by the year 2030.

Global Home Infusion Therapy Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels as well as provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the home infusion therapy market report on the basis of type, application, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Product
    • Infusion Pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
    • Intravenous Sets
    • IV Cannulas
    • Needleless Connectors
  • Services
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Anti-Infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athlete
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Russia
    • Sweden
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Singapore
    • Thailand
    • Philippines
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Egypt
    • Rest of Middle East & Africa (MEA)

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Home Infusion Therapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Home Infusion Therapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Home Infusion Therapy Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Home Infusion Therapy Market: Type Movement Analysis
  • 4.3. Global Home Infusion Therapy Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
  • 4.4. Product
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Infusion Pumps
      • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Elastomeric
      • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Electromechanical
        • 4.4.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Gravity
        • 4.4.5.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Others
        • 4.4.6.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Intravenous Sets
      • 4.4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.8. IV Cannulas
      • 4.4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.9. Needleless Connectors
  • 4.5. Services
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Home Infusion Therapy Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Home Infusion Therapy Market: Application Movement Analysis
  • 5.3. Global Home Infusion Therapy Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Anti-Infective
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Endocrinology
    • 5.5.1. Diabetes
      • 5.5.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Others
      • 5.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Hydration Therapy
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Athlete
      • 5.6.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.3. Others
      • 5.6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Chemotherapy
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Enteral Nutrition
    • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.9. Parenteral Nutrition
    • 5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.10. Specialty Pharmaceuticals
    • 5.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Home Infusion Therapy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Continuous Bioprocessing Market By Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key Country Dynamics
      • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.1.3. Competitive Scenario
      • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.1.3. Competitive Scenario
      • 6.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Netherlands
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.6.3. Competitive Scenario
      • 6.5.6.4. Netherlands Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Belgium
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.7.3. Competitive Scenario
      • 6.5.7.4. Belgium Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Switzerland
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.8.3. Competitive Scenario
      • 6.5.8.4. Switzerland Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.9. Russia
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.9.3. Competitive Scenario
      • 6.5.9.4. Russia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.10. Sweden
      • 6.5.10.1. Key Country Dynamics
      • 6.5.10.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.10.3. Competitive Scenario
      • 6.5.10.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.1.3. Competitive Scenario
      • 6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.4. South Korea
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Indonesia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Indonesia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Malaysia
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.7.3. Competitive Scenario
      • 6.6.7.4. Malaysia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Singapore
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.8.3. Competitive Scenario
      • 6.6.8.4. Singapore Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.9. Thailand
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.9.3. Competitive Scenario
      • 6.6.9.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.10. Philippines
      • 6.6.10.1. Key Country Dynamics
      • 6.6.10.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.10.3. Competitive Scenario
      • 6.6.10.4. Philippines Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.1.3. Competitive Scenario
      • 6.7.1.4. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.4.3. Competitive Scenario
      • 6.7.4.4. Colombia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.5. Chile
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.5.3. Competitive Scenario
      • 6.7.5.4. Chile Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8. Middle East & Africa (MEA)
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.1.3. Competitive Scenario
      • 6.8.1.4. Middle East & Africa (MEA)Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.3. South Africa
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.3.3. Competitive Scenario
      • 6.8.3.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.4. South Arabia
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.4.3. Competitive Scenario
      • 6.8.4.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.5. UAE
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.5.3. Competitive Scenario
      • 6.8.5.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.6. Israel
      • 6.8.6.1. Key Country Dynamics
      • 6.8.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.6.3. Competitive Scenario
      • 6.8.6.4. Israel Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.7. Egypt
      • 6.8.7.1. Key Country Dynamics
      • 6.8.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.7.3. Competitive Scenario
      • 6.8.7.4. Egypt Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key Company Heat Map Analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Baxter
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Type Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. B. Braun SE
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Type Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. BD
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Type Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Fresenius Kabi AG
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Type Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. ICU Medical, Inc.
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Type Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Terumo Corporation
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Type Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. JMS Co. Ltd.
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Type Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Option Care Health, Inc.
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Type Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. CareCentrix, Inc.
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Type Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Coram LLC.
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Type Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. PharMerica Corporation
      • 7.4.11.1. Company Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Type Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. Moog Inc.
      • 7.4.12.1. Company Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Type Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. Amedisys, Inc.
      • 7.4.13.1. Company Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Type Benchmarking
      • 7.4.13.4. Strategic Initiatives

List of Tables

  • Table 1 : List of abbreviations
  • Table 2 Home infusion therapy market (USD Million), 2018 - 2030
  • Table 3 Global home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global home infusion therapy market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America home infusion therapy market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 10 U.S. home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 13 Mexico home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 14 Mexico home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe home infusion therapy market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 17 Europe home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 18 UK home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 19 UK home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 20 Germany home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 22 France home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 23 France home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 24 Spain home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 25 Spain home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 26 Italy home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 27 Italy home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 28 Netherlands home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 29 Netherlands home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 30 Belgium home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 31 Belgium home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 32 Switzerland home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 33 Switzerland home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 34 Russia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 35 Russia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 37 Sweden home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific home infusion therapy market, by country, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 41 Japan home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 42 Japan home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 43 China home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 44 China home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 45 India home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 46 India home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 47 Australia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 48 Australia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 49 South Korea home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 50 South Korea home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 51 Indonesia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 52 Indonesia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 53 Malaysia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 54 Malaysia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 55 Singapore home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 56 Singapore home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 57 Thailand home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 58 Thailand home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 59 Philippines home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 60 Philippines home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 61 Latin America home infusion therapy market, by country, 2018 - 2030 (USD Million)
  • Table 62 Latin America home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 64 Brazil home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 65 Brazil home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 66 Argentina home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 67 Argentina home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 68 Colombia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 69 Colombia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 70 Chile home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 71 Chile home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa home infusion therapy market, by country, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 74 Middle East & Africa home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 75 South Africa home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 76 South Africa home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 77 South Arabia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 78 South Arabia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 79 UAE home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 80 UAE home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 81 Israel home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 82 Israel home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 83 Egypt home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 84 Egypt home infusion therapy market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Home infusion therapy market: Market outlook
  • Fig. 10 Home infusion therapy competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Home infusion therapy market driver impact
  • Fig. 16 Home infusion therapy market restraint impact
  • Fig. 17 Home infusion therapy market strategic initiatives analysis
  • Fig. 18 Home infusion therapy market: Type movement analysis
  • Fig. 19 Home infusion therapy market: Type outlook and key takeaways
  • Fig. 20 Product market estimates and forecast, 2018 - 2030
  • Fig. 21 Infusion Pumps market estimates and forecast, 2018 - 2030
  • Fig. 22 Elastomeric market estimates and forecast, 2018 - 2030
  • Fig. 23 Electromechanical market estimates and forecast, 2018 - 2030
  • Fig. 24 Gravity market estimates and forecast, 2018 - 2030
  • Fig. 25 Other market estimates and forecast, 2018 - 2030
  • Fig. 26 Intravenous Sets market estimates and forecast, 2018 - 2030
  • Fig. 27 IV Cannulas market estimates and forecast, 2018 - 2030
  • Fig. 28 Needleless Connectors market estimates and forecast, 2018 - 2030
  • Fig. 29 Services market estimates and forecast, 2018 - 2030
  • Fig. 30 Home infusion therapy market: Application movement analysis
  • Fig. 31 Home infusion therapy market: Application outlook and key takeaways
  • Fig. 32 Anti-Infective market estimates and forecasts, 2018 - 2030
  • Fig. 33 Endocrinology market estimates and forecasts, 2018 - 2030
  • Fig. 34 Diabetes market estimates and forecasts, 2018 - 2030
  • Fig. 35 Other market estimates and forecasts, 2018 - 2030
  • Fig. 36 Hydration Therapy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Athlete market estimates and forecasts, 2018 - 2030
  • Fig. 38 Other market estimates and forecasts, 2018 - 2030
  • Fig. 39 Chemotherapy market estimates and forecasts, 2018 - 2030
  • Fig. 40 Enteral Nutrition market estimates and forecasts, 2018 - 2030
  • Fig. 41 Parenteral Nutrition market estimates and forecasts, 2018 - 2030
  • Fig. 42 Speciality Pharmaceuticals market estimates and forecasts, 2018 - 2030
  • Fig. 43 Other market estimates and forecasts, 2018 - 2030
  • Fig. 44 Global home infusion therapy market: Regional movement analysis
  • Fig. 45 Global home infusion therapy market: Regional outlook and key takeaways
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 51 UK market estimates and forecasts, 2018 - 2030
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 53 France market estimates and forecasts, 2018 - 2030
  • Fig. 54 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 55 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 56 Netherlands market estimates and forecasts, 2018 - 2030
  • Fig. 57 Belgium market estimates and forecasts, 2018 - 2030
  • Fig. 58 Switzerland market estimates and forecasts, 2018 - 2030
  • Fig. 59 Russia market estimates and forecasts, 2018 - 2030
  • Fig. 60 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 62 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 63 China market estimates and forecasts, 2018 - 2030
  • Fig. 64 India market estimates and forecasts, 2018 - 2030
  • Fig. 65 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 67 Indonesia market estimates and forecasts, 2018 - 2030
  • Fig. 68 Malaysia market estimates and forecasts, 2018 - 2030
  • Fig. 69 Singapore market estimates and forecasts, 2018 - 2030
  • Fig. 70 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 71 Philippines market estimates and forecasts, 2018 - 2030
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 73 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 74 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 75 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 76 Chile market estimates and forecasts, 2018 - 2030
  • Fig. 77 Middle East & Africa (MEA) market estimates and forecasts, 2018 - 2030
  • Fig. 78 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 79 South Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 80 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 81 Israel market estimates and forecasts, 2018 - 2030
  • Fig. 82 Egypt market estimates and forecasts, 2018 - 2030